Table 1.
Summary of Potential Clinical Outcomes in the Hypothetical Patient Scenarios.
| Scenario | BGMS | |||
|---|---|---|---|---|
| A | B | C | D | |
| 1: 61 mg/dL | No clinical impact | Hyperglycemia due to excessive food intake | Failure to detect hypoglycemia | No clinical impact |
| 2: 75 mg/dL | No clinical impact | No clinical impact | Driving/flying below 90 mg/dL | No clinical impact |
| 3: 141 mg/dL | No clinical impact | Delay of therapy intervention | No clinical impact | No clinical impact |
| 4A: 251 mg/dL | No clinical impact | No clinical impact | No clinical impact | Failure to prevent ketoacidosis |
| 4B: 251 mg/dL | No clinical impact | No clinical impact | Hypoglycemia due to insulin overcorrection | No clinical impact |
| 15 mg/dL/% agreement rate |
100.0% | 100.0% | 98.0% | 99.5% |
| 10 mg/dL/% agreement rate |
99.5% | 92.0% | 86.0% | 91.5% |
The colors green, amber, and red indicate low, moderate, and high risk of the specified event. The last rows provide the percentage of BGMS readings that fall within ±15/10 mg/dL of reference values <100 mg/dL, and ±15/10% of reference values ≥100 mg/dL.
Abbreviation: BGMS, blood glucose monitoring system.